Akèy › Twoub depresif majè › Arkansas › Little Rock
Etid klinik pou Twoub depresif majè nan Little Rock, AR
14 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Little Rock (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Ap rekriteFaz 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Ap rekriteFaz 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi lwen
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Ap rekriteFaz 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi lwen
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Ap rekriteFaz 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
- Neurocrine Clinical Site, Bryant · 15 mi lwen
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Ap rekriteFaz 3
- SanRo Clinical Research Group, Bryant · 15 mi lwen
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Ap rekriteFaz 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Ap rekriteFaz 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Bryant · 15 mi lwen
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Ap rekriteFaz 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi lwen
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Ap rekriteFaz 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Ap rekriteFaz 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, Little Rock
Etid Twoub depresif majè nan lòt vil
- New York City, NY36 etid
- Boston, MA31 etid
- Atlanta, GA25 etid
- Philadelphia, PA23 etid
- Orlando, FL19 etid
- Miami, FL18 etid
- Chicago, IL17 etid
- Tampa, FL17 etid
- San Diego, CA16 etid
- Houston, TX16 etid
- Austin, TX13 etid
- Las Vegas, NV13 etid
Lòt etid nan Little Rock
- Skizofreni19 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi13 etid
- Kansè Poumon ki pa ti selil13 etid
- Obèsite11 etid
- Kansè Endomèt10 etid
- Depresyon10 etid
- Dyabèt Tip 210 etid
- Kansè poumon9 etid
- Maladi kadyovaskilè9 etid
- Kansè vejik9 etid
- Ensifizyans kadyak9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.